Nova Laboratories
About
Company description
Our story began in 1997 at the back of a humble community pharmacy in Sungai Pelek where our founder had an idea to develop an effective product from a local plant, known as Phyllanthus niruri, for people who were suffering from liver diseases. The research took 10 long years to bear fruit as our founder successfully developed the world’s first patented Phyllanthus niruri standardised extract (EPN 797), which is used in our liver tonic supplement – Hepar-P.
We are committed to provide health solutions that are clinically proven to be safe and effective. To support the utilisation of Hepar-P in clinical settings by healthcare professionals, we initiated a comprehensive clinical trial in 2018 which concluded in 2021 and achieved positive results. Hepar-P was effective in improving liver fibrosis and reducing liver-specific enzyme (ALT), while remaining safe and well-tolerated throughout the 52 weeks of the study.
